# Abzena secures $5M ADC manufacturing contract with US biotech

Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and GMP manufacturing services for an antibody-drug conjugate (ADC) valued at over $5 million. Services will be carried out in Bristol, PA and San Diego, CA.

- Type: Contract
- Announced: 2017-12-11
- Where: Bristol, Pennsylvania; San Diego, California, United States
- Value: $5.00M
- Status: announced
- Products: antibody-drug conjugate (ADC)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Abzena](https://endata.com/companies/28707.md) (supplier)

## Sources

- [biospace.com](https://www.biospace.com/abzena-secures-contract-for-integrated-adc-manufacturing-services-to-u-s-biotech-company), 2017-12-11: "The value of the entire process development and GMP manufacturing services exceeds $5 million, with the majority of the services to be provided within the next 12 months."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.